{"cluster": 36, "subcluster": 32, "abstract_summ": " Type I and III interferons (IFN-\u03b1/\u03b2 and IFN-\u03bb) are host-produced antiviral cytokines and currently considered as COVID-19 therapy . Here we show that IFN signalling interferes with lung repair during influenza recovery . IFN signals in epithelia, inducing localised antiviral immunity . IfN-induced p53 directly reduces epithelial proliferation and differentiation, increasing disease severity ."}